
#249 – Albert Bourla: Pfizer CEO
Lex Fridman Podcast
00:00
Navigating Drug Development and Trust
This chapter explores the intricate landscape of drug development, regulatory challenges, and the ongoing pressures faced by pharmaceutical companies. It emphasizes the importance of transparency and ethical practices in rebuilding public trust, especially in light of past controversies. The discussion also highlights the balance between innovation, regulatory oversight, and the moral obligations of the industry.
Transcript
Play full episode